Abbey Medical Practice Personalised Diabetic Care Wednesday 10 th September 2014.

Slides:



Advertisements
Similar presentations
Type 2 diabetes Implementing NICE guidance 2009 NICE clinical guideline 87.
Advertisements

Diabetes Overview Managing Diabetes in Primary Care.
A Resource for Glycaemic management in Type 2 DM Hypoglycaemia is dangerous: Beware in Elderly/RF/CVS risk Sulphonureas need education to avoid risk Do.
A Resource for Glycaemic management in Diabetes key messages Hypoglycaemia is dangerous: Beware in elderly/RF/CVS risk Sulphonylureas need education to.
Katee Lira, PharmD PGY2 Ambulatory Care Pharmacy Resident
JARDIANCE: Newly Approved Drug to Lower HbA1C in Type-2 diabetes
 GLP -1 (gut hormone) + GIP = incretin effect =Augmentation of insulin after oral glucose  Type 2 diabetics little incretin effect  Reduced GLP-1 secretion.
Keith Tolley, Director, Tolley Health Economics Ltd IDF Europe Symposium 30 th September Tolley Health Economics Ltd Strategic Consulting in Health.
The New HbA1c HbA1c – DCCT (%) HbA1c – IFFC (mmol/mol)
DIABETES WORKSHOP IN GENERAL PRACTICE Dr John Rochford GP Sharnbrook.
Diabetes for the AKT September We reproduce below our feedback from AKT 16 which sadly continues to apply in AKT 17. Please re-read! “In the last.
Type 2 diabetes in adults NICE guideline Draft for consultation, January to March 2015 Dr Roger Gadsby MBE.
Farxiga™ - Dapagliflozin
Diabesity Management Colette Walter, NP. Objectives 1. Pharmacologic management and understanding of treatment related to the overweight diabetic patient.
Barriers to Diabetes Control Mark E. Molitch, MD.
Novel Antidiabetics: Should they be used at all - and in whom?
Drugs used in Diabetes Dr Sally Hudson. BIGUANIDES reduce output of glucose from the liver and enhances uptake and use of glucose by muscle cells ExampleADVANTAGESDISADVANTAGESCOSTCaution.
Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.
UK/TB/0213/0017a February 2013 New treatment options Dr Craig Parkinson.
Randomized, double-blind, multicenter, controlled trial.
ACUTE STROKE — Hypertension is a common problem in patients with both type 1 and type 2 diabetes but the time course in relation to the duration.
Management of Type 2 Diabetes New Zealand Guidelines Group.
SHEFFIELD GUIDELINES: RENAL DISEASE IN DIABETES Dr Jenny Stephenson GP, Stannington Medical Centre
Oral hypoglycemic drugs Prof. Mohammad Alhumayyd.
Erectile Dysfunction Stephen Mark Christchurch. Normal erectile function: Physical and Psychological factors.
Managing type-2 diabetes in primary care in south camden - a focus on insulin conversion.
UKHDS (UKPDS): UK Hypertension in Diabetes Study Purpose To determine whether tight control of blood pressure (aiming for BP
Prevention Of Diabetes. Type 2 Diabetes: Hyperglycemia Insulin Resistance Relative Impairment of Insulin Secretion Pathogenesis: Poorly Understood Genetic.
Background There are 12 different types of medications to lower blood sugar levels in patients with type 2 diabetes. It is widely agreed upon that metformin.
Type 2 diabetes treatment: Old and New Emily Szmuilowicz, MD, MS Assistant Professor of Medicine Division of Endocrinology Northwestern University.
New Medications for Diabetes
DH206: Pharmacology Chapter 21: Diabetes Mellitus Lisa Mayo, RDH, BSDH.
Efficacy and Safety of Canaglifozin, a Sodium- Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes Featured Article:
SGLT-2 Inhibitors Surprising New Information. Logic for SGLT-2 Inhibition : My Own Comment on MOA- Logic for Benefit: 1.Kidney is an ‘active player’ in.
#4 Management of Diabetes Mellitus. 5 Components of Diabetes Management 5 Components of Diabetes Management Farrell, M. (2005). Textbook of Medical-Surgical.
MODERN ART in TYPE 2 DIABETES Ken McHardy CRAIGMONIE HOTEL, INVERNESS 11 TH Nov 2011.
1 ‘Medicines used in the management of Type 2 Diabetes’ Dr Susan McGeoch, Specialist Registrar in Diabetes Sandra Wilson, Diabetes Specialist Nurse.
Who is considered elderly? “Young old” years “Old, old” >75 years.
Prescribing in cardiovascular disease By Jole Hannan Medicines Optimisation Pharmacist.
Diabetes in the older person Terry Aspray Tuesday pm.
Primary Care Prescribing for Type 2 Diabetes Dr. David Jenkins Worcestershire Royal Hospital.
1 NICE 2015 guidelines to help us treat T2 diabetes in 2016? Paul Newrick Consultant Physician WAHNHST 2016.
A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes Clerk 陳威任.
Utilizing Anti-diabetic Agents to Manage Cardiovascular Disease in T2DM Patients James LaSalle, D.O., FAAFP.
Drugs for Type 2 Diabetes – where next after metformin ?
Diabetes Learning Event 7th October 2016
Management of Diabetes in the Older Person
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
Metformin Use in Chronic Kidney Disease
Type 2 diabetes in adults NICE guideline Draft for consultation, January to March 2015 Dr Roger Gadsby MBE.
Istanbul Medeniyet University
Empagliflozin (Jardiance®)
Primary Efficacy End Point.
Management of Diabetes in the Older Person
Updates on Outcomes for Novel T2D Therapies
Nat. Rev. Nephrol. doi: /nrneph
Type 2 diabetes.
Diabetes and CV Risk Reduction: Cardiologists’ Perspectives on the Latest Outcomes Data.
Integrated Diabetes Care: How Can We Make the Best Use of New Technology?
Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA
Antihyperglycemic therapy in type 2 diabetes: general recommendations
RCHC’s Cardiovascular Health Initiative
Antihyperglycemic Therapy
Patient Selection for Modern T2D Agents
Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA
Priorities for Type 2 Diabetes
Type 2 Diabetes Subgroup
Oral hypoglycemics Jennifer R Marks, MD.
Antihyperglycemic therapy in adults with type 2 diabetes
Presentation transcript:

Abbey Medical Practice Personalised Diabetic Care Wednesday 10 th September 2014

Abbey Medical Practice: Semi-rural, dispensing practice Cover 200 miles 2 4 Partners, 1 GP Assistant, 3 Practice Nurses 7702 Patients Diabetics make up 5.5% of Patient Population: Type 2 Diabetics (5.11%) - 30 Type 1 Diabetics (0.39%)

Annual UK Cost of Diabetes: £ 9.8 billion Drugs: 2% (£196 million) Complications: 98% (£9704 million) Early tight control reduces long-term complications. Poor compliance with medication is responsible for poor control and thus increased complications. Using better tolerated but more expensive drugs is cost effective in the long-term.

Improved Metformin Compliance Metformin is the primary drug for T2D One chance to get patients on Metformin Standard preparation has higher incidence of GI SEs and require multiple dosing Modified Release preparations better tolerated & only once daily Start 500mg Metformin SR once daily, increasing to 2g once daily over 3-4 weeks

Sulphonylureas ProsCons Cheap (but not very cheerful!)WEIGHT GAIN Hypoglycaemia Need to test BM with driving ? CVS Sequelae

Pioglitazone ProsCons EffectiveWeight Gain (fluid retention) V.Low risk of HypoglycaemiaNot in heart failure Good lipid profileNot in undiagnosed Haematuria/Bladder cancer Reduced dose in elderly

DPP-4 Inhibitors (Gliptins) ProsCons WEIGHT LOSSIncreased risk of Pancreatitis V.Low risk of HypoglycaemiaReduced dose in CKD Well toleratedRelatively expensive Novel (long-term data unknown)

GLP-1 ProsCons WEIGHT LOSSNausea V.Low risk of HypoglycaemiaSC daily/weekly injection Expensive Novel (long-term data unknown)

Alpha-Glucosidase Inhibitors ProsCons WEIGHT LOSSNausea V.Low risk of HypoglycaemiaDiarrhoea Germans like it!Poorly tolerated

SGLT-2 Inhibitors ProsCons WEIGHT LOSSGlycosuria V.Low risk of HypoglycaemiaUG thrush Expensive Novel (long-term data unkown)

UKPDS Single most important factor to reduce long- term complications of T2D is BP control. (And the key to BP control is Patient compliance)

Antihypertensives ClassProsCons ACEiCheap Renal Protection Dry Cough in 10-15% ARBWell tolerated Renal Protection Best agent is expensive (Olmesartan) Alpha BlockerCheapOedema, Postural Hypotension Beta BlockerCheapMetabolic profile, ED, Contraindicated Asthma Calcium AntagonistCheapOedema DiureticCheapMetabolic profile, ED

Conclusion Improve patient compliance to reduce complication rate, and therefore costs. Use the best tolerated and most effective medication where possible. Tailor care to the individual patient – review depends on BP, eGFR, Microalbuminuria and HbA 1 c Nurses are infinitely better than doctors for following protocols and are the key to getting good results and reducing long-term complications & NHS costs